Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5371 to 5385 of 7684 results

  1. Referral criteria for joint replacement: What are the most important indicators that someone with osteoarthritis (including shoulder osteoarthritis) would benefit from joint replacement? For example: - presence of night pain - non-response to non-pharmacological interventions - joint instability symptoms - presence of flares - numerical summary scores.

    Recommendation ID NG226/12 Question Referral criteria for joint replacement: What are the most important indicators that someone with osteoarthritis

    Research recommendation
    Published
    7 November 2022

  2. Blood pressure targets for people with aortic aneurysm: What are the optimal blood pressure targets in adults with hypertension and aortic aneurysm, and does this vary by age?

    Recommendation ID NG136/07 Question Blood pressure targets for people with aortic aneurysm: What are the optimal blood pressure targets

    Research recommendation
    Published
    11 April 2022

  3. Blood pressure targets for people with prior ischaemic or haemorrhagic stroke: What are the optimal blood pressure targets in adults with prior ischaemic or haemorrhagic stroke, and does this vary by age?

    Recommendation ID NG136/08 Question Blood pressure targets for people with prior ischaemic or haemorrhagic stroke: What are the optimal

    Research recommendation
    Published
    11 April 2022

  4. What are the optimal frequency and tools for self-monitoring body weight and associated behaviours in populations with a healthy weight?

    Recommendation ID NG7/3 Question What are the optimal frequency and tools for self-monitoring body weight and associated behaviours in

    Research recommendation
    Published
    9 June 2015

  5. The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart failure:- What are the optimal NT-proBNP thresholds for diagnosing heart failure in people with stage IIIb, IV or V chronic kidney disease?

    Recommendation ID NG106/4 Question The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart failure:- What

    Research recommendation
    Published
    17 December 2018

  6. Risk assessment, referral criteria and shared care: What is the association between risk factors and CKD outcomes in children and young people?

    Recommendation ID NG203/10 Question Risk assessment, referral criteria and shared care: What is the association between risk factors and

    Research recommendation
    Published
    30 September 2021

  7. What is the benefit of bilateral cochlear implantation compared with unilateral cochlear implantation in adults with severe to profound deafness?

    Recommendation ID TA566/1 Question What is the benefit of bilateral cochlear implantation compared with unilateral cochlear implantation

    Research recommendation
    Published
    13 May 2019

  8. Continuous glucose monitor sensor adhesive to prevent sensitivities: What is the best continuous glucose monitor sensor adhesive to prevent sensitivities to the device, for example local skin reactions?

    Recommendation ID NG18/03 Question Continuous glucose monitor sensor adhesive to prevent sensitivities: What is the best continuous glucose

    Research recommendation
    Published
    8 April 2022

  9. What is the best way of monitoring the local system for distributing vitamin D supplements?

    Recommendation ID PH56/5 Question What is the best way of monitoring the local system for distributing vitamin D supplements? Any

    Research recommendation
    Published
    9 June 2015

  10. Obesity management for people with a condition associated with an increased risk of obesity: What is the best way to deliver obesity management interventions to people with particular conditions associated with increased risk of obesity (such as people with a physical disability that limits mobility, a learning disability or enduring mental health difficulties)?

    Recommendation ID CG189/06 Question Obesity management for people with a condition associated with an increased risk of obesity: What is

    Research recommendation
    Published
    30 September 2022

  11. Effective ways of supporting women to start and continue interventions for pelvic floor dysfunction: What is the best way to support women to start and continue interventions for pelvic floor dysfunction (for example, apps, decision aids, or behavioural change techniques)?

    Recommendation ID NG210/18 Question Effective ways of supporting women to start and continue interventions for pelvic floor dysfunction:

    Research recommendation
    Published
    7 January 2022

  12. Duration of follow up: What is the clinical and cost effectiveness for different durations of follow up for people with differentiated thyroid cancer who have been treated?

    Recommendation ID NG230/02 Question Duration of follow up: What is the clinical and cost effectiveness for different durations of follow

    Research recommendation
    Published
    6 January 2023

  13. Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for 3 years for people with recurrent calcium renal or ureteric stones?

    Recommendation ID NG118/4 Question Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for

    Research recommendation
    Published
    7 March 2019

  14. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and calcium channel blockers, including compared with placebo, for adults with aortic regurgitation?

    Recommendation ID NG208/15 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  15. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?

    Recommendation ID NG208/16 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021